May 7 is deadline for comments on FDA expanding OTC distribution of drugs for common conditions

05/1/2012

The comment period on FDA’s recent proposal to approve certain prescription drugs for over-the-counter (OTC) distribution closes May 7, and stakeholders should weigh in on whether or not they support a new paradigm that would eliminate some doctor visits to improve patient access to the medicines they need. “The stakes are high because success here means better health for individuals and better public health outcomes,” said Coalition for Healthcare Communication John Kamp, who applauded the FDA for “jump-starting a public conversation” on removing patient access barriers. Read more.

View Full Article in:

http://www.cohealthcom.org/2012/04/30/proposed-otc-drug-distribution-would-expan...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA